This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
See Cramer's multi-million dollar portfolio for FREE and get his new book Get Rich Carefully! Learn More

Alexion Pharmaceuticals Inc.
ALXN : NASDAQ : Health Care

$145.42 | %
Today's Range: 0.00 - 0.00
Avg. Daily Volume: 1,950,700
04/15/14 - 3:59 PM ET

PEER GROUP: Biotechnology

Ticker Company Name Recent
Net Sales
Net Income
ALXN ALEXION PHARMACEUTICALS INC 144.19 28525.11 114.44 1551.35 36.78
BMRN BIOMARIN PHARMACEUTICAL INC 61.29 8884.84 n/m 548.49 9.53
AMGN AMGEN INC 114.11 86322.73 17.16 18676.00 8.17
INCY INCYTE CORP 47.13 7801.76 n/m 354.95 19.48
BIIB BIOGEN IDEC INC 287.35 67927.82 36.75 6932.20 25.66
CELG CELGENE CORP 139.98 56834.68 41.54 6493.90 17.92
ICPT INTERCEPT PHARMA INC 264.68 5325.36 n/m 1.62 74.78
REGN REGENERON PHARMACEUTICALS 293.62 28747.75 77.27 2104.75 52.68
GRFS GRIFOLS SA 38.62 16155.21 27.78 3777.83 9.31
VRTX VERTEX PHARMACEUTICALS INC 65.69 15510.26 n/m 1211.98 -20.64
GILD GILEAD SCIENCES INC 65.48 100698.61 35.78 11201.69 15.45
The peer group comparison is based on Major Biotechnology companies of comparable size.

Price Earnings Comparison

ALXN Ind Avg S&P 500
114.44 43.67 18.29

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV

Latest Stock Upgrades/Downgrades

Brokerage Partners

Top Rated Stocks Top Rated Funds Top Rated ETFs